Clinical Trial Update: Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports results for Treximet (sumatriptan/naproxen) in the prevention and modification of migraine progression; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: Cady, Roger, M.D. | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2013-05-21